Core Scientific
CORZ

Core Scientific (CORZ) analyst forecast and price target

Analyst forecast

Buy

Consensus of 23 analyst ratings

Buy
21
Hold
2
Sell
0
Average price target
$32.40+124.14% vs. last price
Last $14.46
Low $16.00High $42.00

Based on 10 analyst targets

Recent analyst ratings

FirmActionRatingPrice targetDate
Canaccord GenuityMaintainedBuy$36.00Oct 15, 2026
BTIGMaintainedBuy$38.00Oct 15, 2026
Cantor FitzgeraldMaintainedOverweight$39.00Oct 14, 2026
UBSInitiated CoverageBuy$24.00Sep 23, 2026
Rothschild & CoInitiated CoverageNeutral$16.00Sep 21, 2026
Wells FargoInitiated CoverageOverweight$28.00Sep 17, 2026
B. Riley SecuritiesMaintainedBuy$42.00 from $33.00Aug 3, 2026
Keefe, Bruyette & WoodsUpgradedMarket Perform → Outperform$28.00 from $25.00Jul 30, 2026
Canaccord GenuityMaintainedBuy$36.00 from $30.00Jul 29, 2026
NeedhamMaintainedBuy$35.00 from $29.00Jul 29, 2026
MacquarieMaintainedOutperform$38.00 from $35.00Jul 29, 2026
NeedhamMaintainedBuy$29.00Jul 28, 2026
BTIGMaintainedBuy$38.00Jul 28, 2026
BTIGMaintainedBuy$38.00 from $33.00Jun 25, 2026
Freedom BrokerInitiated CoverageHold$33.00Jun 16, 2026
B. Riley SecuritiesMaintainedBuy$33.00 from $30.00May 27, 2026
JefferiesMaintainedBuy$37.00 from $24.00May 14, 2026
BTIGMaintainedBuy$33.00 from $23.00May 13, 2026
NeedhamMaintainedBuy$29.00 from $23.00May 7, 2026
MacquarieMaintainedOutperform$35.00 from $28.00May 7, 2026

Frequently asked questions

  • What is the price target for CORZ stock?

    The average 12-month analyst price target for Core Scientific (CORZ) is $32.40, with a high estimate of $42.00 and a low of $16.00, across 10 analysts.

  • Is CORZ a buy, sell, or hold?

    Analysts covering Core Scientific currently average a Buy rating: 21 buy, 2 hold and 0 sell, from 23 analysts. Ratings reflect analyst opinion, not investment advice.

  • What upside do analysts see for CORZ?

    The average price target of $32.40 implies 124.14% upside from the last price of $14.46.

  • What is the latest analyst rating on CORZ?

    On Oct 15, 2026, Canaccord Genuity maintained Core Scientific at Buy with a price target of $36.00.

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.